Middle East Respiratory Syndrome

Coronavirus [MERS-CoV] Infections

103.05.21


WHO20129

DIC
2014520(

)()(
)()



2-14

DIC

 ()

MERS-CoV

20(Alagaili et .Al., mBio

2014)

 ()
MERS-CoV

MERS-CoV(4)
72
(Memish et al., EID 2014; van Doremalen et al., EID
2014)


WHOMiddle East
Respiratory Syndrome coronavirus

2014516WHO614
181
WHO
http://www.who.int/csr/don/archive/disease/co
ronavirus_infections/en/

Updated: 2014/05/19

Updated: 2014/05/19



MERS-CoV
MERS-CoV(
)
WHO

WHAAFP

WHOMERS-CoV1/2
WHO4/243-4
3

:
75%(secondary cases)
4
2
(possible tertiary cases)

10

WHOMERS-CoV2/2

MERS-CoV

11


101103
103314
WHO
10267

MERS-CoV

1346

121

1145

16

693

152

6062

-
13

14


2012/9/27

2013/3/14

2013/6/7

15



()
()

16




(38)

17


14

18

19

1/2
24

()
()

24

20

2/2

14

MERS-CoV

21

3 mL

2-8()
22



14

23

24

1/2
~~

(
)

25

2/2
~~

24

26


(
)

24

27

1/5

(N95
())

28

2/5

a.
b.

3/5
()

/,
()

4/5

(
)

N95()

(
) (

(aerosol)

()

b.
c.
d.
(aerosol)N95()
e. N95()
f. ()

5/5


14

14

32

33


24
2PCR
24

34



14

15

()
35

SpO290%
SpO29295%



36


20123

(http://www.cdc.gov.tw)
37

38